Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain

Inclusion Criteria: 1. Meets the diagnostic criteria of traditional Chinese and Western medicine for sequelae of pelvic inflammatory disease and chronic pelvic pain; 2. Transvaginal ultrasound examination shows thickening of the fallopian tube wall and fluid accumulation in the lumen, which may be accompanied by pelvic free fluid or fallopian tube ovarian masses; 3. The age range is 18-50 years old, married or with a history of sexual activity; 4. Those with a menstrual cycle of 21-35 days; 5. 4 points ≤ Pain Visual Analog Scale (VAS) \< 7 points; 6. Those who have signed an informed consent form and are willing to receive treatment. Exclusion Criteria: 1. Female patients who have fertility requirements during pregnancy, lactation, or in the short term; 2. Patients with gynecological diseases such as organic lesions of the reproductive system or gynecological acute abdomen; 3. Chronic pelvic pain caused by gynecological tumors, endometriosis, pelvic congestion syndrome, uterine fibroids, tuberculous pelvic inflammatory disease, and other diseases confirmed through examination; 4. Those with severe diseases such as cardiovascular, cerebrovascular, liver and kidney function, and digestive system; 5. Individuals with mental abnormalities and psychological disorders; 6. Individuals with allergic constitution or known allergies to the drugs and their components used in this experiment; 7. Patients currently participating in clinical trials of other drugs; 8. Other methods of treatment have already been or are currently being carried out, which may affect the indicators observed in this study.